A citation-based method for searching scientific literature

Greta Alì, Rossella Bruno, Gabriella Fontanini. J Thorac Dis 2018
Times Cited: 19







List of co-cited articles
97 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Aliya Noor Husain, Thomas V Colby, Nelson G Ordóñez, Timothy Craig Allen, Richard Luther Attanoos, Mary Beth Beasley, Kelly Jo Butnor, Lucian R Chirieac, Andrew M Churg, Sanja Dacic,[...]. Arch Pathol Lab Med 2018
230
36

Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Harry C Hwang, Brandon S Sheffield, Stephanie Rodriguez, Kim Thompson, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2016
96
31

The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
Francoise Galateau-Salle, Andrew Churg, Victor Roggli, William D Travis. J Thorac Oncol 2016
145
26

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Marta Cigognetti, Silvia Lonardi, Simona Fisogni, Piera Balzarini, Vilma Pellegrini, Andrea Tironi, Luisa Bercich, Mattia Bugatti, Giulio Rossi, Bruno Murer,[...]. Mod Pathol 2015
136
26

The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Alberto M Marchevsky, Nolwenn LeStang, Kenzo Hiroshima, Giuseppe Pelosi, Richard Attanoos, Andrew Churg, Lucian Chirieac, Sanja Dacic, Aliya Husain, Andras Khoor,[...]. Hum Pathol 2017
28
21


Malignant Mesothelioma Mortality - United States, 1999-2015.
Jacek M Mazurek, Girija Syamlal, John M Wood, Scott A Hendricks, Ainsley Weston. MMWR Morb Mortal Wkly Rep 2017
71
21

A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
Yoshiaki Kinoshita, Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara, Kenzo Hiroshima, Yoshinao Oda, Kazuki Nabeshima. Cancer Cytopathol 2018
50
21

Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
Sonja Klebe, Noel A Brownlee, Annabelle Mahar, James L Burchette, Thomas A Sporn, Robin T Vollmer, Victor L Roggli. Mod Pathol 2010
80
15

Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
Tomoyuki Hida, Shinji Matsumoto, Makoto Hamasaki, Kunimitsu Kawahara, Tohru Tsujimura, Kenzo Hiroshima, Toshiaki Kamei, Kenichi Taguchi, Akinori Iwasaki, Yoshinao Oda,[...]. Cancer Sci 2015
25
15

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Anna C Bibby, Selina Tsim, Nikolaos Kanellakis, Hannah Ball, Denis C Talbot, Kevin G Blyth, Nick A Maskell, Ioannis Psallidas. Eur Respir Rev 2016
99
15

Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors.
Jamal Carter, James Adam Miller, David Feller-Kopman, David Ettinger, David Sidransky, Zahra Maleki. Ann Am Thorac Soc 2017
36
15

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.
Evan W Alley, Juanita Lopez, Armando Santoro, Anne Morosky, Sanatan Saraf, Bilal Piperdi, Emilie van Brummelen. Lancet Oncol 2017
273
15

New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
Andrew Churg, Brandon S Sheffield, Francoise Galateau-Salle. Arch Pathol Lab Med 2016
92
15

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara, Akinori Iwasaki, Tatsuro Okamoto, Yoshinao Oda, Hiroshi Honda,[...]. Lung Cancer 2017
71
15

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.
Catherine T-S Chung, Gilda Da Cunha Santos, David M Hwang, Olga Ludkovski, Melania Pintilie, Jeremy A Squire, Ming-Sound Tsao. J Clin Pathol 2010
64
15

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.
Brandon S Sheffield, Harry C Hwang, Anna F Lee, Kim Thompson, Stephanie Rodriguez, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2015
107
15

Exposure to asbestos: past, present and future.
Enrico Pira, Francesca Donato, Luisa Maida, Gianluigi Discalzi. J Thorac Dis 2018
13
15

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Hedy L Kindler, Nofisat Ismaila, Samuel G Armato, Raphael Bueno, Mary Hesdorffer, Thierry Jahan, Clyde Michael Jones, Markku Miettinen, Harvey Pass, Andreas Rimner,[...]. J Clin Oncol 2018
166
10

Pleural Disease.
David Feller-Kopman, Richard Light. N Engl J Med 2018
75
10

Diagnosis and prognosis-review of biomarkers for mesothelioma.
Huan H Sun, Allen Vaynblat, Harvey I Pass. Ann Transl Med 2017
25
10

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis.
Fraser J H Brims, Tarek M Meniawy, Ian Duffus, Duneesha de Fonseka, Amanda Segal, Jenette Creaney, Nicholas Maskell, Richard A Lake, Nick de Klerk, Anna K Nowak. J Thorac Oncol 2016
55
10

Invited review-next-generation sequencing: a modern tool in cytopathology.
Sinchita Roy-Chowdhuri, Pasquale Pisapia, Manuel Salto-Tellez, Spasenija Savic, Mariantonia Nacchio, Dario de Biase, Giovanni Tallini, Giancarlo Troncone, Fernando Schmitt. Virchows Arch 2019
15
13


An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting.
K Goto, M Satouchi, G Ishii, K Nishio, K Hagiwara, T Mitsudomi, J Whiteley, E Donald, R McCormack, T Todo. Ann Oncol 2012
87
10

EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
Yuri Sheikine, Deepa Rangachari, Danielle C McDonald, Mark S Huberman, Erik S Folch, Paul A VanderLaan, Daniel B Costa. Clin Lung Cancer 2016
33
10

Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.
Yi-Lin Chen, Chung-Ta Lee, Cheng-Chan Lu, Shu-Ching Yang, Wan-Li Chen, Yang-Cheng Lee, Chung-Hsien Yang, Shu-Ling Peng, Wu-Chou Su, Nan-Haw Chow,[...]. PLoS One 2016
13
15

Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples.
Y Guan, Z J Wang, L Q Wang, D F Hua, J Liu. Genet Mol Res 2016
14
14


Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
C Bozzetti, F V Negri, C A Lagrasta, P Crafa, C Bassano, I Tamagnini, G Gardini, R Nizzoli, F Leonardi, D Gasparro,[...]. Br J Cancer 2011
104
10

A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer.
Manabu Soda, Kazutoshi Isobe, Akira Inoue, Makoto Maemondo, Satoshi Oizumi, Yuka Fujita, Akihiko Gemma, Yoshihiro Yamashita, Toshihide Ueno, Kengo Takeuchi,[...]. Clin Cancer Res 2012
101
10

Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.
Fiamma Buttitta, Lara Felicioni, Maela Del Grammastro, Giampaolo Filice, Alessia Di Lorito, Sara Malatesta, Patrizia Viola, Irene Centi, Tommaso D'Antuono, Roberta Zappacosta,[...]. Clin Cancer Res 2013
81
10



EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
Jiyoul Yang, Ok-Jun Lee, Seung-Myoung Son, Chang Gok Woo, Yusook Jeong, Yaewon Yang, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han. Cancer Res Treat 2018
17
11


Refractory left pleural effusion in an older patient: Atypical presentation of colorectal carcinoma.
Yujie Yuan, Jinning Ye, Chuangqi Chen, Wu Song, Jianbo Xu, Jianhui Chen, Yaping Xing, Yulong He. Oncol Lett 2015
2
100

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Antonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, Brittany E Harvey, Pamela B Mangu, John M S Bartlett, Michael Bilous, Ian O Ellis, Patrick Fitzgibbons, Wedad Hanna,[...]. Arch Pathol Lab Med 2018
201
10

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
Gillian Ellison, Guanshan Zhu, Alexandros Moulis, Simon Dearden, Georgina Speake, Rose McCormack. J Clin Pathol 2013
206
10


HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible?
Daniel D Wong, W Bastiaan de Boer, Michael A Platten, Vickie Y Jo, Edmund S Cibas, M Priyanthi Kumarasinghe. Diagn Cytopathol 2015
14
14

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer.
Donna M Graham, Vicky M Coyle, Richard D Kennedy, Richard H Wilson. Curr Colorectal Cancer Rep 2016
24
10

EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
Shang-Gin Wu, Yao-Wen Kuo, Yih-Leong Chang, Jin-Yuan Shih, Ya-Hui Chen, Meng-Feng Tsai, Chong-Jen Yu, Chih-Hsin Yang, Pan-Chyr Yang. J Thorac Oncol 2012
78
10


Evaluation and treatment of malignant ascites secondary to gastric cancer.
Hiromichi Maeda, Michiya Kobayashi, Junichi Sakamoto. World J Gastroenterol 2015
33
10

Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma.
Soo-Ryum Yang, Chieh-Yu Lin, Henning Stehr, Steven R Long, Christina S Kong, Gerald J Berry, James L Zehnder, Christian A Kunder. J Mol Diagn 2018
21
10

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma.
Andreja Gornjec, Srdjan Novakovic, Vida Stegel, Marko Hocevar, Ziva Pohar Marinsek, Barbara Gazic, Mateja Krajc, Erik Skof. BMC Cancer 2019
8
25

Risk of Procedural Hemorrhage.
Krysta S Wolfe, John P Kress. Chest 2016
16
12

Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
Chang Dong Yeo, Jin Woo Kim, Kwan Hyoung Kim, Jick Hwan Ha, Chin Kook Rhee, Seung Joon Kim, Young Kyoon Kim, Chan Kwon Park, Sang Haak Lee, Mi Sun Park,[...]. Lung Cancer 2013
49
10

Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.
Birgitta Schlüter, Roswitha Gerhards, Dirk Strumberg, Rudolf Voigtmann. J Cancer Res Clin Oncol 2010
13
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.